Researchers exploring semaglutide versus tirzepatide side effects find broadly similar GI profiles between the two medications
That alone can double your urinary output
Important limitations: No detailed tumor biology or treatment data No information on whether patients consistently took the medications No weight change data Possible unmeasured differences between groups despite matching Many patients had not been followed for the full 10 years, so later long-term estimates are based on fewer patients and are less precise So what does this mean
February 25, 2026: Zepbound Label Updated with Warning of Severe Gastrointestinal Issues The FDA has posted an updated Zepbound warning label, which includes reports of gastrointestinal issues that patients claim they experienced after Zepbound reached the market
The real question isn't which one is "better." It's which one aligns best with your goals, training style, and lifestyle
Learn about the foods you should eat to make sure you get enough vitamin B12 in your diet
